Paravita (RUBIMED AG)
Welcome to the PulseAid listing for the Paravita drug offered from RUBIMED AG. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | RUBIMED AG |
NON-PROPRIETARY NAME: | Formica rufa, Sus Scrofa Cerebellum, Acetylcholine, and Scabies Lesion Lysate (Human) |
SUBSTANCE NAME: | FORMICA RUFA; SUS SCROFA CEREBELLUM; ACETYLCHOLINE; SCABIES LESION LYSATE (HUMAN) |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2015-05-07 |
END MARKETING DATE: | 0000-00-00 |
Paravita HUMAN OTC DRUG Details:
Item Description | Paravita from RUBIMED AG |
LABELER NAME: | RUBIMED AG |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 12; 21; 30; 200([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL) |
START MARKETING DATE: | 2015-05-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 66343-004_fbd55255-19c8-4811-a7c3-3ecdf217e948 |
PRODUCT NDC: | 66343-004 |
APPLICATION NUMBER: | |
Other FORMICA RUFA; SUS SCROFA CEREBELLUM; ACETYLCHOLINE; SCABIES LESION LYSATE (HUMAN) Pharmaceutical Manufacturers / Labelers: